Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Starling GmbH is a public intelligence company based in Zurich, Switzerland. Founded in 2011, it focuses on life sciences and consumer health. It is not a traditional SEO tool; instead, it monitors social media, forums, patient communities, regulatory filings, press releases, and public moves by competitors, turning open-source signals into structured information for competitive intelligence, market research, and patient insights.
Its core services include public intelligence monitoring, intelligent intelligence infrastructure development, Japan market public intelligence expansion, and capability-building training. Starling emphasizes an “AI first-pass + human analysis” workflow: AI processes large volumes of mentions first, and analysts then filter for signals that truly matter. Deliverables mentioned in its case materials include monthly briefings, Share of Voice analysis, real-time alerts, support for brand factbooks, influence network mapping, and patient persona methodologies. Its industry taxonomy, therapeutic-area classifiers, and ability to interpret healthcare context are key differentiators from general-purpose social listening platforms.
The text indicates coverage across public sources such as social media, patient communities, digital channels, forums, LinkedIn hiring activity, conference reactions, patient advocacy organizations, and Japanese pharmaceutical news. Languages include English, German, French, and Japanese, with regional coverage across Europe, the Americas, and Asia. Japan capability is a clear selling point, led by a person with Japanese-language skills and Tokyo business relationships, enabling the team to capture local signals before they appear in English-language reporting. However, scale figures on the page were extracted as 0, so the actual number of therapeutic areas monitored and years of operation cannot be verified.
The website does not disclose pricing, plans, free trials, or payment methods. The offering is likely more project-based or delivered as a managed service. On the integration side, there is also no public information about APIs, BI tools, or connections to third-party marketing platforms. That said, Starling can provide a “digital intelligence layer” for CI and market research organizations, and can design automated collection and classification pipelines.
Its strengths are deep vertical experience in healthcare, broad coverage of public signal sources, strong multilingual capabilities—especially in Japan—and the ability to replace a client’s need to build monitoring infrastructure in-house. Limitations include opaque pricing, an incomplete public list of platform and data-source coverage, and poor fit for teams that only need keyword rankings, backlinks, or technical SEO audits. It is better suited to pharmaceutical companies, life sciences competitive intelligence teams, consumer health brands, and consulting or market research firms looking to strengthen their digital monitoring capabilities.
The website’s accessibility from mainland China cannot be determined from the available text and is marked as unknown. Payment methods are also not disclosed. Chinese teams looking for similar capabilities may compare it with Brandwatch, Talkwalker, Meltwater, Sprinklr, Similarweb, Semrush, or local public-opinion monitoring and pharmaceutical data providers.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on starlingpartners.com official site.
starlingpartners.com is an Switzerland API & Data provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach starlingpartners.com directly.